Trial intelligence / Profile preview

Generic Fluticasone/Salmeterol vs Advair Diskus in Asthma

NCT03562923Phase 3Unknown

Sponsor
Amneal Pharmaceuticals, Inc.
Start
Oct 2018
Primary completion
May 2019
Modality
Small Molecules
01

Overview

A Phase 3 trial of salmeterol + fluticasone in asthma, sponsored by Amneal Pharmaceuticals, Inc.. Status: unknown.

02

Drugs

salmeterol + fluticasone
03

Conditions

asthma

Beyond the preview

Go deeper on NCT03562923.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03562923.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call